nxpharmagen.comContact us
About company
NX PharmaGen’s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company’s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield:
US
Unknown
Not verified company
